image
Lifecore Biomedical, Inc. LFCR
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 6.4
-4.19 %
$ 236 M
Market Cap
49.23
P/E
CASH FLOW STATEMENT
-217 K OPERATING CASH FLOW
99.37%
Growth Rates
1Year 99.37%
3Years -0.48%
5Years -0.27%
7Years -0.11%
10Years -0.10%
-17.9 M INVESTING CASH FLOW
-331.52%
Growth Rates
1Year -331.52%
3Years -18.19%
5Years 28.63%
7Years 4.65%
10Years -3.00%
7.51 M FINANCING CASH FLOW
-81.09%
Growth Rates
1Year -81.09%
3Years 61.29%
5Years -37.55%
7Years 16.16%
10Years 11.78%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Lifecore Biomedical, Inc.
image
Net Income 9.33 M
Depreciation & Amortization 8.86 M
Capital Expenditures -17.9 M
Stock-Based Compensation 6.2 M
Change in Working Capital -3.84 M
Others -16.6 M
Free Cash Flow -18.1 M

Cash Flow

Millions
May-2024 May-2023 May-2022 May-2021 May-2020 May-2019 May-2018 May-2017 May-2016 May-2015 May-2014 May-2013 May-2012 May-2011 May-2010 May-2009 May-2008 May-2007 May-2006 May-2005 May-2004 Oct-2002 Oct-2001 Oct-2000 Oct-1999 Oct-1998 Oct-1997 Oct-1996
OPERATING CASH FLOW
Net Income 9.3 (102.2) (97.2) (32.7) (38.2) 0.4 24.9 10.7 (11.4) 13.7 19.3 22.8 13.1 4.3 4.0 7.7 13.5 29.2 8.7 5.4 2.9 (1.5) (4.8) (2.1) (2.8) (2.9) (8.6) (4.2)
Depreciation & Amortization 8.9 13.5 17.8 19.9 18.8 15.2 12.4 10.7 9.4 7.1 7.1 7.3 5.6 5.3 3.4 3.1 3.2 3.3 3.2 3.5 3.7 3.5 5.4 6.1 2.2 2.1 1.1 0.5
Deferred Income Tax 0.2 0.4 (6.9) (7.9) (5.4) 0.9 (7.2) 2.5 (9.9) 3.7 3.7 5.2 (0.8) 2.5 3.2 2.6 (0.6) 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 6.2 3.61 K 2.64 K 3.3 K 2.38 K 3.6 4.4 4.0 3.5 1.6 1.4 1.7 1.9 2.0 1.0 0.9 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities (20.9) 28.2 66.0 23.5 33.0 (2.9) (4.6) 0.9 32.8 (3.2) (9.7) (11.8) (5.8) 3.3 0.2 (2.1) 0.5 (24.0) (0.9) 0.6 0.6 2.2 (2.5) 1.1 0 (0.2) 3.0 100 K
Change in Working Capital (3.8) 22.1 (6.7) 8.9 (27.7) (1.2) (10.1) 0.6 (2.5) 3.3 (0.8) (4.0) 8.2 (2.9) (4.3) (2.8) 0.8 (10.5) 87 K 3.6 0.7 (4.3) (5.7) 76 K (3.0) (2.4) (1.0) 100 K
Cash From Operations (0.2) (34.5) (24.4) 15.0 (17.0) 16.0 19.8 29.3 21.8 26.2 21.0 21.2 22.2 14.5 7.5 9.4 17.5 (2.1) 10.9 13.0 7.9 (0.1) (7.6) 5.0 (3.6) (3.4) (5.5) (3.6)
INVESTING CASH FLOW
Capital Expenditures (17.9) (20.8) (28.1) (23.8) (26.7) (44.7) (33.6) (22.6) (40.9) (17.5) (14.9) (8.9) (5.4) (6.7) (44.9) (4.6) (4.2) (6.8) (4.7) (3.7) (3.4) (2.5) (7.0) (5.3) (4.1) (4.5) (1.3) (0.4)
Other Items 0 16.6 109.9 12.9 2.8 (52.1) (2.0) (2.4) (0.7) (16.9) 1.5 (1.5) (38.7) (22.7) 2.1 (7.8) (16.0) 48.8 (0.7) (1.5) 2.0 10.1 3.0 (10.3) 1.0 8.6 7.0 (20.3)
Cash From Investing Activities (17.9) (4.2) 81.8 (10.9) (23.9) (96.8) (35.6) (25.0) (41.6) (34.4) (13.3) (10.4) (44.1) (29.4) (42.8) (12.3) (20.2) 42.0 (5.5) (5.2) (1.4) 7.5 (4.0) (15.6) (3.1) 4.1 5.7 (20.7)
FINANCING CASH FLOW
Common Stock Repurchased (0.2) 0 (0.8) (0.4) 0 0 0 0 0 0 0 0 (5.0) (1.2) 0 0 (19.5) (7.4) 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 2.7 3.1 (55.4) 7.5 41.8 54.9 18.9 (8.6) 15.6 8.1 (9.9) (14.7) 39.2 (3.9) 19.6 0 0 7.3 (1.1) (5.9) (4.5) (15.9) 6.3 6.6 0.3 (6.7) (0.6) (0.2)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 4.8 31.8 (1.6) (10.9) (1.8) 23.8 (5.7) (0.9) (0.5) (0.6) (3.1) (8.0) 1.7 0.2 (0.3) 1.6 2.9 (0.6) 75 K (0.7) (0.4) 0 (0.2) (0.1) 0 8.9 (8.8) 100 K
Cash From Financing Activities 7.5 39.7 (57.0) (3.4) 40.0 79.0 13.3 (8.8) 15.6 8.2 (7.2) (19.3) 35.9 (4.8) 19.7 2.0 (15.5) 2.1 2.3 (1.4) (3.8) (8.3) 11.6 17.0 0.7 3.3 (9.2) 34.9
CHANGE IN CASH
Net Change In Cash (10.6) 17.4 0.3 0.7 (0.9) (1.8) (2.5) (4.5) (4.2) (0.1) 0.5 (8.5) 14.0 (19.7) (15.6) (0.9) (18.2) 42.0 7.6 6.4 2.8 (0.8) 59 K 6.4 (6.0) 4.0 (9.0) 10.6
FREE CASH FLOW
Free Cash Flow (18.1) (55.2) (52.5) (8.8) (43.7) (28.7) (13.8) 6.7 (19.1) 8.6 6.2 12.4 16.8 7.8 (37.4) 4.9 13.3 (8.8) 6.1 9.4 4.5 (2.6) (14.5) (0.3) (7.7) (7.9) (6.8) (4.0)